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Quality improvement report
Integrating evidence based medicine into routine clinical
practice: seven years’ experience at the Hospital for
Tropical Diseases, London
Diana N J Lockwood, Margaret Armstrong, Alison D Grant
Abstract
Problem Introduction and evaluation of evidence
based medicine (EBM) into routine hospital practice.
Strategy for change Routine EBM meetings
introduced in 1997.
Design Review of outcomes of meetings from 1997
to 2004, focusing on their effect on clinical practice.
Setting Referral centre for tropical and domestic
infectious diseases.
Key measure for improvement Outcome of
meetings, classified as resulting in a change in
practice; confirmation or clarification of existing
practice; identification of a need for more evidence;
and outcome unclear.
Effects of change Examples include a change from
inpatient to day case treatment of New World
cutaneous leishmaniasis; development of guidelines
on the treatment of coinfection with visceral
leishmaniasis and HIV; and identification of the need
for more data on the efficacy and toxicity of
atovaquone-proguanil (Malarone) compared with
quinine plus sulfadoxine-pyrimethamine (Fansidar) in
the treatment of uncomplicated falciparum malaria,
which resulted in a clinical trial being set up.
Lessons learnt Incorporation of EBM meetings into
our routine practice has resulted in treatment
guidelines being more closely based on published
evidence and improvements to care of patients.
Written summaries of the meetings are important to
facilitate change.
Background
Evidence based medicine (EBM) was introduced to the
Hospital for Tropical Diseases in London in 1997. We
were enthusiastic about making our practice more evi-
dence based but initially daunted by the potential mag-
nitude of the task. The hospital is a centre for tropical
and domestic infectious diseases, taking local, national,
and international referrals, and has a major role in
advising on the management of imported infectious
diseases in the United Kingdom. Our medical team
consists of ten consultants, two specialist registrars, and
three senior house officers. The hospital has had writ-
ten guidelines since the 1960s; originally these detailed
the doses of drugs used for tropical diseases, whereas
now they deal with medical management of diseases
common in our practice. The guidelines are updated
regularly, according to consensus of consultant
opinion. Two consultants were early converts to EBM
and proposed the introduction of regular meetings for
all medical staff, in which evidence concerning a
specific question relevant to our practice would be
reviewed by the team. These meetings have become an
established part of our routine.
Key measures for improvement
We considered that care of patients would be improved
if our treatment guidelines were based on the
best available evidence, maximising efficacy and
convenience and minimising toxicity. We categorised
the outcome of EBM meetings in terms of their impli-
cations for clinical practice: meetings resulting in a
change in practice; meetings confirming or clarifying
existing practice; meetings identifying the need for
more evidence (which may be combined with the pre-
vious two categories); and meetings with no clear out-
come. We gathered this information from the meeting
minutes filed in our library and, more recently, on our
intranet.
The process of EBM
We aim to have one EBM meeting every two months,
each lasting two hours over a Friday lunchtime. The
meeting chairperson is allocated by rotation among
the consultants and specialist registrars, though any
team member who wants to investigate a particular
clinical question can lobby to chair the next available
meeting. The chairperson chooses the question to be
addressed, identifies articles to be reviewed, and
distributes these articles among the members of staff
who will attend the meeting, aiming for each person to
be allocated one or two articles. Those given articles
review them in detail beforehand, then present the
key points from each paper at the meeting. We have
produced notes to help the chairperson prepare for
the meeting (see box), and for reviewers, giving
guidance on critical appraisal and references to
key EBM texts (see further details on bmj.com).
See bmj.com for details of notes given to chair of meeting
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Outside experts may be invited if this will facilitate
discussion.
At the meeting the selected papers are presented in
an order determined by the chairperson. After each
paper we take points of clarification, but the main dis-
cussion is deferred until the end, when we try to reach
consensus about the evidence presented. After the
meeting, the chairperson writes a summary that is
circulated to all medical staff and stored on our
intranet and in the library, along with a copy of the
papers presented. Our clinical guidelines are updated
if appropriate.
Outcome of EBM meetings
Between January 1997 and March 2004 we had 29
meetings. The questions discussed primarily con-
cerned clinical management of diseases common in
our practice, including the use of laboratory diagnostic
and monitoring tests, the use of specific drug therapies,
and side effects of drugs and how we should manage
them. The table gives some examples of meetings in
each outcome category.
Meetings resulting in a change in practice
Until 2002 we treated patients with New World
cutaneous leishmaniasis as inpatients with 21 days of
intravenous sodium stibogluconate. In an EBM meet-
ing we reviewed published data on the toxicity of
sodium stibogluconate and concluded that serious
cardiac toxicity is rare and predictable, patients with
pre-existing cardiac disease and elderly patients being
at higher risk. An audit of toxicity among our patients
confirmed this view, and sodium stibogluconate treat-
ment is now given on a day case basis to young
patients with no pre-existing heart disease by using an
integrated care pathway developed with our nursing
team.
Meetings identifying the need for more evidence
We reviewed the evidence concerning atovaquone-
proguanil (Malarone) as a treatment for uncompli-
cated falciparum malaria. We concluded there were
insufficient data to justify changing our current first
line regimen from quinine plus sulfadoxine-
pyrimethamine to atovaquone-proguanil and have set
up a randomised controlled trial to compare the
efficacy and toxicity of these two regimens.
Lessons learnt: meeting organisation
We have gradually refined the way we organise the
meetings and have some suggestions for others who
may be considering implementing EBM meetings.
Share out the role of meeting chairperson—The chair
has a key role in the success of the meeting. Important
tasks include refining the question to be addressed so
that it is not too broad or too narrow; doing an effective
literature search; deciding which articles should be
presented in the meeting; allocating each article to an
appropriate person (it may be better to give more
complex articles to people with more experience in lit-
erature appraisal); and writing a summary of the meet-
ing. This is time consuming (perhaps two days’ work in
total), and we rotate this role so that it is not too oner-
ous for any one individual. The chairperson needs to
identify appropriate literature to review; library staff
may be able to advise on literature search strategies.
Having team members trained in critical appraisal is
helpful.
Include key people involved in making practice
guidelines—If the question has implications for current
guidelines, we make sure that key people involved in
decision making attend the meeting. For example, if
the question concerns whether or not a particular
diagnostic test should be done, a senior staff member
from the laboratory concerned should be invited to
take part.
Involve staff at all levels—All members of staff
attending our meetings are given at least one article to
review and present. Guidelines for presenters help to
ensure that people with less experience of literature
appraisal focus on the key issues.
Ensure there is enough time to discuss the evidence—It is
crucial that there is enough time to discuss the
evidence presented. There may be questions or discus-
sion about individual articles. More importantly, there
must be enough discussion time at the end to reach
consensus as to whether practice should be changed.
This may mean restricting the selection of papers that
Notes for the chairperson of the EBM meeting
You need to start preparing at least three weeks ahead
of the meeting. People attending the meeting need to
have their papers to review a week in advance
• Decide on the topic
Well focused questions work best
Keep it clinically relevant
• Do a literature search
Medline/BIDS (library staff can advise on the best
search strategy)
Textbooks
Experts’ reference collection
• Identify any outside experts who may like to
participate
Invite them early
Explain the format of the meeting
Ask them for input into the literature search
• Identify articles to be reviewed in the meeting
Check through the results of the literature search and
identify key papers
• Decide on meeting structure and timing
An overview at the start often works well
Material to be reviewed can often be organised into
sections
Timing is critical—tell presenters how long they have
to talk
• Identify key references
If there is a lot of material, it is better to focus on key
references rather than trying to cover everything
Give key references to people who are definitely
attending and will do concise presentations
• Distribute the allocated paper(s) to each presenter at
least a week in advance
• In the meeting
Allow brief discussion after papers/sections
Keep at least 20 minutes at the end for general
discussion of the evidence
• Produce and circulate a summary within four weeks
of the meeting
Previous summaries can be seen in the EBM file in the
library
• File the meeting summary and the papers reviewed
in the library
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are reviewed in the meeting to those which are most
relevant. Presenters must also keep strictly to time: it
may help to appoint a timekeeper.
Consider appointing a scribe—If there are many
articles to review, it may help to have someone to write
the main findings and conclusions of each study on a
white board or flip chart. This generates a summary of
the evidence presented, which assists discussion at the
end.
Chase the chairperson for a summary of the
meeting—Meetings for which the chairperson does not
produce a written summary for the records are
unlikely to result in a change in practice.
Lessons learnt: effect on practice
EBM meetings are consistently well attended by both
junior and senior members of staff, suggesting they are
popular. We think that the meetings promote an envi-
ronment in which we aim to base our practice on evi-
dence rather than tradition. Staff at all levels are
encouraged to question why we do what we do: a ques-
tion arising on a ward round can lead to an EBM
meeting to investigate the issue and ultimately to a
change in guidelines. When an EBM meeting
concludes that there is little evidence to support what
we do in a specific situation, this may generate ideas for
audit and research. An EBM meeting question may
also arise after publication of an article that seems rel-
evant to our practice. By reviewing the new article
along with other relevant publications, we get a more
balanced view as to whether our practice should
change. EBM meetings bring together all staff involved
in the care of our patients, including senior house
officers from other teams who provide cross cover for
whom the meetings are a part of the formal training
programme.
Next steps
Some EBM meetings have resulted in a change to our
guidelines that has clear implications for the care of
patients, such as our move from inpatient to day case
administration of sodium stibogluconate for New
World cutaneous leishmaniasis. It is harder to evaluate
formally to what degree the meetings influence staff to
adopt a more critical approach to clinical practice; in
the future we plan to formally audit the views of train-
ees on our EBM meetings.
To date, the issues examined have generally been
about clinical diagnosis and treatment and have
primarily involved medical staff, with contributions
from colleagues in the laboratory disciplines and
pharmacists to discuss specific questions. In the
future we would like to make more meetings
multidisciplinary.
Examples of outcomes of EBM meetings
Outcome and question Conclusion Implication for practice
Change in practice:
Does the published literature support hospital
practice of measuring quinine levels in patients
with malaria on intravenous quinine therapy?
Little relation between total quinine levels and risk of
serious cardiac toxicity
Stopped measuring quinine levels routinely in
patients on intravenous quinine: all patients undergo
ECG before treatment, patients at higher risk of
arrhythmias undergo cardiac monitoring
How serious and common is toxicity from sodium
stibogluconate in treatment of cutaneous
leishmaniasis?
Serious cardiac toxicity is rare and predictable.
Non-cardiac toxicity is common and not clinically
important
Day case treatment of New World cutaneous
leishmaniasis introduced
Should we change from quinine to artemsinins for
the treatment of falciparum malaria?
Little difference in efficacy overall. Artemisinins
useful if high risk of quinine resistance, or of serious
side effects from quinine
Artemisinins now used for falciparum malaria from
Thai border areas, severe malaria from South East
Asia, and in patients with high risk of cardiac toxicity
from quinine
Confirmation of existing practice:
How many days of ciprofloxacin treatment is
needed for typhoid?
No evidence to support reducing to five days’
treatment
No change to current practice
Clarification of existing practice:
What is the optimal treatment for patients with
HIV infection and visceral leishmaniasis?
Treatment with liposomal amphotericin is less toxic
than treatment with pentavalent antimonials. Patients
relapse unless they are on antiretroviral therapy;
secondary prophylaxis may be needed
Liposomal amphotericin should be given as first line
treatment for coinfected patients. Pentamidine
isethionate is the first line agent for secondary
prophylaxis
Need for more evidence identified:
Should returning travellers with diarrhoea be
treated with antibiotics?
Early treatment of travellers’ diarrhoea with a single
dose of ciprofloxacin is safe and effective. No clear
evidence on the value of antibiotics for returning
travellers with diarrhoea lasting >3 days
No evidence to guide practice for returning travellers
with diarrhoea for >3 days. A study could be
developed to examine this question
Should uncomplicated falciparum malaria be
treated with atovaquone-proguanil (Malarone)?
Malarone treatment seems safe and effective but data
are from populations where malaria is endemic, and
no data available to compare with our current
standard of care (quinine plus
sulfadoxine-pyrimethamine (Fansidar))
Randomised controlled trial set up to compare
efficacy and toxicity of Malarone with
quinine-Fansidar
Key learning points
EBM meetings have proved popular in our unit
and, after seven years, remain well attended by
both senior and junior staff
EBM meetings can help to build consensus
around clinical guidelines and ensure that
guidelines evolve to incorporate new evidence
Meetings that conclude that evidence is
lacking provide topics for audit and research
projects
The meetings are most useful when a written
summary is produced
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Overall, we have found EBM meetings a good way
to bring together all members of the team in a way that
builds consensus around practice guidelines and helps
to ensure that our guidelines evolve to incorporate new
evidence.
Contributors: DNJL established and has overseen the EBM ses-
sions since 1997. MA manages the EBM database. ADG had the
idea for the article, which was further developed by DNJL and
MA. ADG and DL wrote the paper. All authors approved the
final paper. ADG is guarantor.
Funding: MA is supported by the Special Trustees of the Hospi-
tal for Tropical Diseases. ADG is supported by a National Public
Health Career Scientist award from the Department of Health.
Competing interests: None declared.
Ethical approval: Not required.
(Accepted 4 August 2004)
Commentary: The fool wonders, the wise (women) ask . . . about
tropical diseases in their practice
Michael L Green
Lockwood and colleagues have shared their seven year
experience of integrating evidence based medicine into
their practice at the Hospital for Tropical Diseases in
London.1 Consultants, assigned as “chairs” in rotation,
identify emerging clinical questions, search the literature
for clinical research studies, assign articles to partici-
pants, and distributematerials in advance of a bimonthly
“EBM meeting.” During these two hour meetings, the
group appraises the evidence and strives to reach a con-
sensus about its implications for their practice.
Reviewing their experience, the group classified the
outcome of each meeting, citing examples that resulted
in a change in practice, confirmed or clarified existing
practice, or identified a need for more evidence. The lat-
ter outcome often provided the impetus for a new
research project. In addition to these concrete changes
in practice, Lockwood and colleagues qualitatively
observed a cultural shift in their institution. Physicians, in
this new atmosphere of inquiry, aimed to base their
decision making on “evidence rather than tradition.”
Importantly, the authors turned inwards and evaluated
the process of their particular model of evidence based
practice. And they kindly offer these lessons learnt, mid-
course corrections, and general guidelines to readers
inspired to adopt it.
This theme issue of BMJ asks the question: Does
EBM “work?” . . . does it really change anything? For
obvious methodological limitations, we cannot draw a
straight line of causality from these EBM meetings,
representing a discreet intervention, to changes in
practice and then to improved outcomes in patients.
None the less, we can say that the authors, clearly a
reflective bunch, embraced EBM and witnessed
substantial changes in their practice, both in their
management of specific conditions and their general
approach to decision making. Furthermore, they com-
mitted not only to a style of practice but to a style of
lifelong learning that is in keeping with an interna-
tional movement towards practice based, self directed
approaches and away from traditional continuing
medical education. I suspect that their electronic “port-
folio” of clinical questions would be more useful than
sitting through conferences on parasitic diseases.
In deciding how to integrate EBM into their practice,
Lockwood and colleagues did their homework. The for-
mat of their meetings bears a striking resemblance to the
EBM curriculums offered by many internal medicine
residency programmes. In several studies, participants in
these curriculums improved their EBM knowledge,
skills, and certain behaviours.2 3 At Yale, our residents,
with faculty guidance, have brought their clinical
questions to weekly EBM seminars since 1995.4
However, we enjoy the luxury of protected time in a
training programme. The longevity of the EBMmeeting
at the Hospital for Tropical Diseases (seven years and
still going strong) demonstrates its feasibility for busy cli-
nicians in “routine practice.”
Finally, the authors’ experience adds tropical medi-
cine to the growing number of settings in which suffi-
cient evidence exists to guide many clinical decisions. It
would be interesting for them to determine more pre-
cisely, as did Ellis and colleagues, the exact proportion
of therapeutic manoeuvres in their practice that were
supported by systematic reviews of randomised
controlled trials, individual randomised controlled
trials, or “convincing non-experimental evidence.”5
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Endpiece
Discoveries
Discoveries are often made by not following
instructions; by going off the main road; by trying
the untried.
Frank Tyger
Syed Hasan, senior house officer in surgery, Great
Yarmouth
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